The Clinical and Economic Burden of Idiopathic Hypersomnia and Narcolepsy: A United States Claims-Based Analysis
Individuals with narcolepsy and idiopathic hypersomnia experience comorbid conditions which bear consequences for healthcare systems; these may be considered when evaluating overall health of individuals with either condition.
Authors
- Marisa Whalen
- D. Profant (ORCID: https://orcid.org/0000-0003-4323-9348)
- Prasheel Lillaney
- Weiyi Ni (ORCID: https://orcid.org/0000-0003-4244-0699)
- Ragy Saad (ORCID: https://orcid.org/0000-0001-6117-5320)
- Sarah Coseo Markt (ORCID: https://orcid.org/0000-0003-2873-0358)
- Elizabeth M. Poole (ORCID: https://orcid.org/0000-0002-4680-4587)
- Douglas S. Fuller (ORCID: https://orcid.org/0000-0002-2448-5896)
- Trevor Alvord (ORCID: https://orcid.org/0009-0005-9428-4060)
- Patricia Prince (ORCID: https://orcid.org/0000-0002-0705-6942)
- Jed E. Black (ORCID: https://orcid.org/0000-0002-2812-2435)
- Shaina Desai (ORCID: https://orcid.org/0000-0003-2497-4777)
Institutions
- Jazz Pharmaceuticals (United States) (US)
- Aetion (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- Nature and Science of Sleep
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/nss.s498213
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00